Ушбу ишга иқтибос қилган ишлар

2 та иш

Иш: Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study

1. Translational research of new developments in targeted therapy of colorectal cancer

   Lei Yang, N. E. Atakhanova, Meryelem Tania Churampi Arellano +9

   Шарҳ мақолаColorectal Cancer Treatments and StudiesPathology - Research and Practice20230 иқтибос

   ABIABI:AkademIndex/openalex/2023.review-article.000055

2. Senescence-related signatures predict prognosis and response to immunotherapy in colon cancer

   Xiaoshan Hu, Xiongjie Zhu, Yifan Chen +7

   МақолаTelomeres, Telomerase, and SenescenceJournal of Gastrointestinal Oncology20240 иқтибос

   ABIABI:AkademIndex/openalex/2024.article.002648